Like so many people with MS, Mariska Breland remembers the disease’s onset as a combination of strange, seemingly disparate maladies that included tingling in her left thigh, numb feet, skin that felt “too thick” around her toes, foot drop, and double vision. One left her…
MS in Motion - a Column by Mike Knight
Editor’s note: This is the first of a three-part series about Pilates and MS. When I was diagnosed with MS in December 2013, my most visible symptom was a waltzing shuffle that was slowly changing my once-purposeful gait into a wobble (leading some co-workers to believe…
It was my 2015 annual check-in, and my neurologist and I were in the exam room. I was sitting on one of those little stools with wheels, he was leaning across the exam table. We had just finished discussing my steadily worsening symptoms and treatment plan, which consisted…
“Is the MS drug news good for u?” my friend’s text asked. It was Wednesday morning, March 29. Genentech had just announced that Ocrevus, the “First and only approved disease-modifying therapy for primary progressive form of multiple sclerosis (PPMS) – one of the most disabling forms of…
Recommended Posts
- Blood levels of key protein may help predict MS progression
- Eye scans link retinal thinning to slower cognitive processing in MS
- In a life with multiple sclerosis, you have to know when ‘it is time’
- More antibody bands in spinal fluid tied to broader MRI lesions in MS
- Briumvi may outperform other MS therapies, indirect comparison shows